Navigation Links
AlphaRx Shareholder Update
Date:6/24/2009

ING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.


'/>"/>
SOURCE AlphaRx Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
2. AlphaRx Signs Cooperative Research and Development Agreement with US Army
3. AlphaRx Provides Corporate and Development Update
4. AlphaRxs Indaflex(TM) Continues its Clinical Development
5. AlphaRx CEO Accumulates More Company Shares
6. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
7. AlphaRx Announces Debt Conversion
8. AlphaRx To Present at 47th Annual ICAAC
9. All Seven Members of RBC Life Sciences Board of Directors Were Re-Elected During the Companys 2009 Annual Shareholders Meeting
10. Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)
11. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/-SentinelleMedicalInc.,aleadingmanufactur...launchesasuiteofnewleadingedgeclinicalapplications...year,sRadiologicalSocietyofNorthAmerica(RSNA)annua...A).Theapplicationsleveragetheuniquehighqualityimag...sandsupportmultipleimagingmodalitiesformulti-param...
(Date:11/25/2009)...25/PRNewswire/--TheBayAreaAirQualityManagementDist...he Air Alert forThursday,November26,2009wh...olidfuel,bothindoorsandoutdoors. ,, "Cold,still...,"saidJackBroadbent,executiveofficeroftheAirDistri...ftheirneighborsandfellowcommunitymembersthisThanks...
(Date:11/25/2009)...y that grew out of a collaboration between UCLA en...e to the nearly 10 million Americans who suffer fr... as hardening of the arteries, peripheral arterial...in which narrowed arteries reduce blood flow to th...r vascular disease, heart attack and stroke, and i...
(Date:11/25/2009)... Evaluation and treatment clinics to resume Monday...cus) November 25, 2009 -- Centegra Health System i... vaccine shots at four Centegra Primary Care (CPC)...cine has arrived. The clinics are at CPC sites in ...ill be open as follows: ,   From 4:30 ...
(Date:11/25/2009)...Newswire/-- MISSIONSkincare ®isproudtosupport...artofGNC,sannualSt.Jude ThanksandGiving campaign,$...w SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addit...or$10donationatcheckoutatoneoftheir5,000+retailloc...forSt.Judeduringtheir2009 ThanksandGiving campaign...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...t the drugs may indicate more severe depression, r...y , , MONDAY, March 9 (HealthDay News) -- ...htened risk for sudden cardiac death, although the...chers said. , "We suspect that their use is a mar...
...NEWTOWN, Pa., March 9 CONNEXION Healthcare (CXHC)... Chief Operations Officer. In this role, Michael w...wth of CXHC, including its Clinical CONNEXION and ...09/NE81090 ) , , Michael comes to CXHC with more...
... EDITOR,S PICK: SOX9 renders melanomas sensitive ...mas are often resistant to standard cancer therapi...c acid (RA). Given the lack of available treatment...titutes of Health in Bethesda, Maryland, have now ...
...- PRESIDENT AND CEO RESIGNS - , , ADDISON, Texas,...nnounced the resignation of Kerry P. Gray as Chief...ately. Following his resignation as Chief Executi...sume the position of President and Chief Executive...
...Summer courses are available in condensed format a...professionals gain new knowledge and improve skill...s in Pennsylvania now have even more options to re...program, to include timely, relevant topics, such ...
...KIRKLAND, Wash., March 9 ProteoTech Inc. announ...esident & CSO, and Dr. Luke Esposito, Director...International Conference for Alzheimer,s and Parki...ing promising results pertaining to ProteoTech,s c...
Other Medicine News:Health News:Antidepressant Use Tied to Cardiac Death in Women 2Health News:Antidepressant Use Tied to Cardiac Death in Women 3Health News:Michael Forte Joins CONNEXION Healthcare as Chief Operations Officer 2Health News:JCI online early table of contents: March 9, 2009 2Health News:JCI online early table of contents: March 9, 2009 3Health News:JCI online early table of contents: March 9, 2009 4Health News:JCI online early table of contents: March 9, 2009 5Health News:ULURU Inc. Announces Senior Management Change 2Health News:Penn State Expands Professional Development Program for School Nurses, Now in its Seventh Year 2Health News:ProteoTech to Present at 9th International Conference for Alzheimer's and Parkinson's Disease - Prague, Czech Republic, March 11-15, 2009 2
(Date:11/25/2009)...FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicald...ydisruptivesurgicaltreatmentsforthespine,announced...r30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecall...theCompany,sproductsandwillincludecommentsfrommana...dial-innumbersare1-877-407-4018fordomesticcallersa...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...ugDelivery-USMarketTrends&Analysis http://www...y---US-Market-Trends--Analysis.html ,, TheUSin...ftherapeuticapplicationsfromthedeliveryofconventio...rapeuticdrugs.Thefutureofthetechnologyhingesontoth...
(Date:11/25/2009)...PRNewswire/-- ChemoCentryx,Inc.,announcedtodaytha...theProspectiveRandomizedOralTherapyEvaluationinCro...entswithmoderate-to-severeCrohn,sdiseasedemonstrat...ityprofile.Thestudydemonstratedevidenceofclinicale...70-pointdecreaseintheCrohn,sDiseaseActivityIndex(C...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Embarrassing illnesses no bar to information sharing 52625 1Embarrassing illnesses no bar to information sharing 52625 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 1URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 3Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 1Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 2
...Biopure Corporation,(Nasdaq: BPUR ) announced tod...RC) has submitted a new protocol for review by the...clinical trial of Hemopure(R),[hemoglobin glutamer...f,operational casualties with severe traumatic hem...fusions. The proposed trial hypotheses is that,for...
...ts To Breathe Without Ventilator Clini...AND, June 18 Synapse Biomedical Inc., (http://www...ceived approval from,the U.S. Food and Drug Admini...r-dependent Spinal Cord Injury (SCI) patients who ...he FDA,s approval, SCI patients and,their caregive...
Other Medicine Technology:U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 2U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 2Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 4Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 5Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 6
BANGOLINI LENSES Nos. 2 and 4 IN CASE
BD Visitec IOL Manipulator (Fenzl)
Hunkeler Lens Manipulator
Hunkeler IOL Manipulator
Medicine Products: